Sylvester Comprehensive Cancer Center

  • 20211179 - Crane Tracy

  • Investigator:
    Tracy Crane
    RCname Email

    Coordinator:

    IRB: 20211179

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Multiple

    Sponsor: NCI

    Enrolling Sites:

    Deerfield
    Gables
    Kendall
    Plantation
    Sylvester

    Title:

    Trial of Exercise And Lifestyle (TEAL) Intervention for Women with Ovarian Cancer

    Eligibility Criteria - NCT05761561 *This information has been extracted from " www.clinicaltrials.gov"

  • 20220781 - Nair Navya

  • Investigator:
    Navya Nair
    RCname Email

    Coordinator:

    IRB: 20220781

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Corpus Uteri

    Sponsor: UNIVERSITY OF WASHINGTON

    Enrolling Sites:

    JMH
    Sylvester

    Title:

    Social Interventions for Support during Treatment for Endometrial Cancer and Recurrence (SISTER): a multi-site randomized controlled trial

    Eligibility Criteria - NCT04930159 *This information has been extracted from " www.clinicaltrials.gov"

  • 20200854 - Penedo Frank

  • Investigator:
    Frank Penedo
    RCname Email

    Coordinator:

    IRB: 20200854

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Multiple

    Sponsor: NCI

    Enrolling Sites:

    Community Clinics
    Gables
    Kendall
    Sylvester

    Title:

    Living Well: A Web-Based Program to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors

    Eligibility Criteria - NCT04533763 *This information has been extracted from " www.clinicaltrials.gov"

  • 20201300 - Schlumbrecht Matthew

  • Investigator:
    Matthew Schlumbrecht
    RCname Email

    Coordinator:

    IRB: 20201300

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Ovary

    Sponsor: NRG

    Enrolling Sites:

    Gables
    Sylvester
    UMH

    Title:

    A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NON-INFERIORITY OF SALPINGECTOMY TO SALPINGO-OOPHORECTOMY TO REDUCE THE RISK OF OVARIAN CANCER AMONG BRCA1 CARRIERS

    Eligibility Criteria - NCT04251052 *This information has been extracted from " www.clinicaltrials.gov"

  • 20230506 - Schlumbrecht Matthew

  • Investigator:
    Matthew Schlumbrecht
    RCname Email

    Coordinator:

    IRB: 20230506

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Ovary

    Sponsor: ETCTN

    Enrolling Sites:

    Sylvester

    Title:

    A phase 1/1b dose escalation study of abemaciclib and olaparib for recurrent platinum- resistant ovarian cancer

    Eligibility Criteria - NCT04633239 *This information has been extracted from " www.clinicaltrials.gov"

  • 20231060 - Schlumbrecht Matthew

  • Investigator:
    Matthew Schlumbrecht
    RCname Email

    Coordinator:

    IRB: 20231060

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Sponsor: Seagen Inc

    Enrolling Sites:

    Deerfield
    Gables
    Plantation
    Sylvester
    UMH

    Title:

    A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2

    Eligibility Criteria - NCT06003231 *This information has been extracted from " www.clinicaltrials.gov"

  • 20201370 - Sinno Abdulrahman

  • Investigator:
    Abdulrahman Sinno
    RCname Email

    Coordinator:

    IRB: 20201370

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Multiple

    Sponsor: DEPARTMENT OF DEFENSE

    Enrolling Sites:

    Deerfield
    Gables
    Plantation
    Sylvester
    UMH

    Title:

    2020-0165: Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)

    Eligibility Criteria - NCT04575935 *This information has been extracted from " www.clinicaltrials.gov"

  • 20230999 - Sinno Abdulrahman

  • Investigator:
    Abdulrahman Sinno
    RCname Email

    Coordinator:

    IRB: 20230999

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Multiple

    Sponsor: GOG Foundation

    Enrolling Sites:

    Aventura
    Coral Springs
    Deerfield
    Gables
    Hollywood
    Plantation
    Sylvester
    UMH

    Title:

    A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin versus no HIPEC at the Time of Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Pri

    Eligibility Criteria - NCT05659381 *This information has been extracted from " www.clinicaltrials.gov"

  • 20220813 - Wolfson Aaron

  • Investigator:
    Aaron Wolfson
    RCname Email

    Coordinator:

    IRB: 20220813

    SDG: GYO (Gynecologic Cancer)
    Disease Site(s):

    Corpus Uteri

    Sponsor: SCCC

    Enrolling Sites:

    Gables
    Sylvester

    Title:

    Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma

    Eligibility Criteria - NCT05603910 *This information has been extracted from " www.clinicaltrials.gov"